Rhenman & Partners Asset Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-277,800	Closed	-$1M	–	105
2019 Q3	$1M	Hold	277,800	–	–	0.13%	79
2019 Q2	$745K	Hold	277,800	–	–	0.08%	76
2019 Q1	$822K	Sell	277,800 -125,000	-31%	-$370K	0.1%	74
2018 Q4	$640K	Sell	402,800 -215,000	-35%	-$342K	0.07%	73
2018 Q3	$2.27M	Hold	617,800	–	–	0.23%	67
2018 Q2	$1.75M	Sell	617,800 -50,000	-7%	-$141K	0.18%	69
2018 Q1	$2.48M	Hold	667,800	–	–	0.31%	65
2017 Q4	$1.92M	Sell	667,800 -182,200	-21%	-$525K	0.26%	73
2017 Q3	$3.82M	Buy	850,000 +684,000	+412%	+$3.07M	0.49%	68
2017 Q2	$762K	Hold	166,000	–	–	0.11%	85
2017 Q1	$699K	Hold	166,000	–	–	0.11%	84
2016 Q4	$686K	Sell	166,000 -100,000	-38%	-$413K	0.13%	85
2016 Q3	$2.15M	Hold	266,000	–	–	0.34%	76
2016 Q2	$2.08M	Hold	266,000	–	–	0.37%	75
2016 Q1	$2.05M	Hold	266,000	–	–	0.41%	76
2015 Q4	$2.87M	Sell	266,000 -14,000	-5%	-$151K	0.43%	69
2015 Q3	$1.94M	Hold	280,000	–	–	0.31%	80
2015 Q2	$2.48M	Hold	280,000	–	–	0.3%	88
2015 Q1	$2.76M	Sell	280,000 -88,000	-24%	-$868K	0.47%	75
2014 Q4	$4.51M	Buy	368,000 +168,000	+84%	+$2.06M	1.31%	28
2014 Q3	$2M	Sell	200,000 -130,000	-39%	-$1.3M	0.58%	69
2014 Q2	$2.5M	Buy	+330,000	New	+$2.5M	0.74%	50